Gynecological Drugs Market Size, Share, And Growth Report 2032

Gynecological Drugs Market

Gynecological Drugs Market by Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), by Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, Contraception (Birth Control), and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3926 Published Date: Aug-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 15.61 Billion USD 29.93 Billion 7.5% 2023

Gynecological Drugs Market: Size

The global Gynecological Drugs Market size was worth around USD 15.61 billion in 2023 and is predicted to grow to around USD 29.93 billion by 2032 with a compound annual growth rate (CAGR) of roughly 7.5% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Gynecological Drugs Market on a global and regional level.

Global Gynecological Drugs Market SizeRequest Free Sample

Gynecological Drugs Market: Overview

The treatment of gynecological ailments is purely drug-dependent. In recent times, the gynecological pharmacology field has bloomed like never before. Furthermore, the availability of the ultraprecise advanced gynecological investigation, direct monitoring facility, and various medical options for the treatment of gynecological ailments is increasing. With the establishment of down and up-regulation policies, the different treatment options, such as hypothalamus and pituitary, have now become a very easy tool for gynecologists to treat hormonal disorders. These gynecological disorders include conditions affecting ovaries, uterus, and their appendages.

There are various factors expected to support the growth of the global gynecological drugs market in the future, such as the increasing prevalence of gynecological diseases. Changing lifestyle of females across the globe has eventually put them at a higher risk of suffering from various types of gynecological disorders, which, in turn, is fuelling the global gynecological drugs market. The awareness about one’s well-being and health has increased, which has led to the rise for better gynecological treatments and the manufacturers have innovated newer drugs for treating gynecological disorders with fewer side-effects and better efficacy. These are also projected to fuel this global market.

Global Gynecological Drugs MarketRequest Free Sample

Gynecological Drugs Market: Segmentation

The study provides a decisive view of the gynecological drugs market by segmenting the market based on therapeutics, indication, distribution channel, and region. All the segments have been analyzed based on present and future trends in the market that is estimated from 2024 to 2032.

Based on therapeutics, the market is segmented into hormonal therapy and non-hormonal therapy. Non-hormonal therapy is expected to hold the major market share over the estimated timeline.

Based on the indication, the market is segmented into gynecology infections, gynecology cancers, endometriosis, polycystic ovary syndrome, female infertility, menopausal disorder, contraception (birth control), and others. Polycystic ovary syndrome is expected to grow significantly over the forecast timeline.

Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies held the major share of the global market in 2023.

Gynecological Drugs Market: Report Scope

Report Attributes Report Details
Report Name Gynecological Drugs Market
Market Size in 2023 USD 15.61 Billion
Market Forecast in 2032 USD 29.93 Billion
Growth Rate CAGR of 7.5%
Number of Pages 110
Key Companies Covered Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Pfizer, Inc., Amgen Inc., AstraZeneca, Allergan, and Bayer AG, among others
Segments Covered By therapeutics, By indication, By distribution channel and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Gynecological Drugs Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.

North America is expected to lead the global gynecological drugs market over the forecast timeline, due to the high expenditure on women’s health, substantial research and development activities witnessed in the gynecology domain. Europe is predicted to trail behind North America in terms of growth and be the second largest gynecological drugs market in the years ahead. Asia Pacific is likely to record a high CAGR over the forecast timeframe, owing to the introduction of new and approved gynecological drugs, the presence of strong healthcare infrastructure, increased affordability of the gynecological drugs, and technological advancements.

Gynecological Drugs Market: Competitive Players

Some key players of the gynecological drugs market are:

  • Merck & Co. Inc.
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Amgen Inc.
  • AstraZeneca
  • Allergan
  • Bayer AG

The Global Gynecological Drugs Market is segmented as follows:

Global Gynecological Drugs Market: Therapeutics Analysis

  • Hormonal therapy 
  • Non-Hormonal therapy 

Global Gynecological Drugs Market: Indication Type Analysis

  • Gynecology Cancers
  • Endometriosis
  • Female Infertility
  • Menopausal Disorder
  • Gynecology Infections
  • Polycystic Ovary Syndrome
  • Contraception (Birth Control)
  • Others

Global Gynecological Drugs Market: Distribution Channel Analysis

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Gynecological Drugs Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Gynecological drugs are medications used to treat various conditions related to women's reproductive health. These drugs can address issues ranging from hormonal imbalances and menstrual disorders to fertility challenges and menopause symptoms. 

According to study, the Gynecological Drugs Market size was worth around USD 15.61 billion in 2023 and is predicted to grow to around USD 29.93 billion by 2032.

The CAGR value of Gynecological Drugs Market is expected to be around 7.5% during 2024-2032.
 

North America has been leading the Gynecological Drugs Market and is anticipated to continue on the dominant position in the years to come.

The Gynecological Drugs Market is led by players like Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Pfizer, Inc., Amgen Inc., AstraZeneca, Allergan, and Bayer AG, among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed